- 現金殖利率: 2.71%、總殖利率: 2.71%、5年平均現金配發率: 106.59%
- 要留意資產負債表的未分配盈餘和配息能力, 如果為負值, 可能會無法發放股利
- 股利有2個稅要支出, 分別是綜合所得稅和健保補充保費(單筆股利達2萬元以上, 課2.11%)
| EPS YoY | 現金股利 YoY | 股票股利 YoY | 現金配發率 YoY | 股票配發率 YoY | 全部配發率 YoY | |||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023 (10) | 5.15 | 44.66 | 4.20 | 31.25 | 0.00 | 0 | 81.55 | -9.27 | 0.00 | 0 | 81.55 | -9.27 |
| 2022 (9) | 3.56 | 17.11 | 3.20 | 6.67 | 0.00 | 0 | 89.89 | -8.91 | 0.00 | 0 | 89.89 | -8.91 |
| 2021 (8) | 3.04 | 43.4 | 3.00 | 3.45 | 0.00 | 0 | 98.68 | -27.86 | 0.00 | 0 | 98.68 | -27.86 |
| 2020 (7) | 2.12 | -10.92 | 2.90 | -3.33 | 0.00 | 0 | 136.79 | 8.52 | 0.00 | 0 | 136.79 | 8.52 |
| 2019 (6) | 2.38 | 10.19 | 3.00 | 50.0 | 0.00 | 0 | 126.05 | 36.13 | 0.00 | 0 | 126.05 | 36.13 |
| 2018 (5) | 2.16 | 19.34 | 2.00 | 19.05 | 0.00 | 0 | 92.59 | -0.24 | 0.00 | 0 | 92.59 | -0.24 |
| 2017 (4) | 1.81 | -23.95 | 1.68 | 40.0 | 0.00 | 0 | 92.82 | 84.09 | 0.00 | 0 | 92.82 | 84.09 |
| 2016 (3) | 2.38 | 56.58 | 1.20 | -40.0 | 0.00 | 0 | 50.42 | -61.68 | 0.00 | 0 | 50.42 | -61.68 |
| EPS QoQ YoY | 本業EPS QoQ YoY | 累計EPS QoQ YoY | |||||||
|---|---|---|---|---|---|---|---|---|---|
| 24Q3 (20) | 2.18 | -17.74 | 48.3 | 2.32 | 14.85 | 103.51 | 6.77 | 47.49 | 74.48 |
| 24Q2 (19) | 2.65 | 36.6 | 68.79 | 2.02 | 31.17 | 169.33 | 4.59 | 136.6 | 90.46 |
| 24Q1 (18) | 1.94 | 45.86 | 130.95 | 1.54 | 6.21 | 214.29 | 1.94 | -62.69 | 130.95 |
| 23Q4 (17) | 1.33 | -9.52 | 269.44 | 1.45 | 27.19 | 195.92 | 5.20 | 34.02 | 44.44 |
| 23Q3 (16) | 1.47 | -6.37 | -17.88 | 1.14 | 52.0 | 83.87 | 3.88 | 61.0 | 19.75 |
| 23Q2 (15) | 1.57 | 86.9 | 42.73 | 0.75 | 53.06 | 22.95 | 2.41 | 186.9 | 67.36 |
| 23Q1 (14) | 0.84 | 133.33 | 147.06 | 0.49 | 0.0 | -5.77 | 0.84 | -76.67 | 147.06 |
| 22Q4 (13) | 0.36 | -79.89 | -60.44 | 0.49 | -20.97 | -31.94 | 3.60 | 11.11 | 17.65 |
| 22Q3 (12) | 1.79 | 62.73 | 115.66 | 0.62 | 1.64 | -1.59 | 3.24 | 125.0 | 50.7 |
| 22Q2 (11) | 1.10 | 223.53 | 30.95 | 0.61 | 17.31 | 10.91 | 1.44 | 323.53 | 9.09 |
| 22Q1 (10) | 0.34 | -62.64 | -29.17 | 0.52 | -27.78 | 85.71 | 0.34 | -88.89 | -29.17 |
| 21Q4 (9) | 0.91 | 9.64 | 145.95 | 0.72 | 14.29 | 7.46 | 3.06 | 42.33 | 43.66 |
| 21Q3 (8) | 0.83 | -1.19 | 76.6 | 0.63 | 14.55 | -12.5 | 2.15 | 62.88 | 22.16 |
| 21Q2 (7) | 0.84 | 75.0 | -24.32 | 0.55 | 96.43 | -48.6 | 1.32 | 175.0 | 2.33 |
| 21Q1 (6) | 0.48 | 29.73 | 152.63 | 0.28 | -58.21 | 250.0 | 0.48 | -77.46 | 152.63 |
| 20Q4 (5) | 0.37 | -21.28 | 60.87 | 0.67 | -6.94 | 36.73 | 2.13 | 21.02 | -11.25 |
| 20Q3 (4) | 0.47 | -57.66 | 0.0 | 0.72 | -32.71 | 0.0 | 1.76 | 36.43 | 0.0 |
| 20Q2 (3) | 1.11 | 484.21 | 0.0 | 1.07 | 1237.5 | 0.0 | 1.29 | 578.95 | 0.0 |
| 20Q1 (2) | 0.19 | -17.39 | 0.0 | 0.08 | -83.67 | 0.0 | 0.19 | -92.08 | 0.0 |
| 19Q4 (1) | 0.23 | 0.0 | 0.0 | 0.49 | 0.0 | 0.0 | 2.40 | 0.0 | 0.0 |
| 年/月 | 營收 | 月增率(%) | 去年同期年增率(%) | 累計營收 | 累計營收年增率(%) | 近三月累計營收 | 存貨銷售比 | 自結稅前EPS | 自結稅前累計EPS | 備註(年增率變動50%需說明原因) |
|---|---|---|---|---|---|---|---|---|---|---|
| 2024/10 | 5.55 | -6.24 | 13.48 | 56.68 | 42.81 | 17.95 | N/A | - | ||
| 2024/9 | 5.92 | -8.76 | 21.43 | 51.13 | 46.93 | 18.86 | 0.33 | - | ||
| 2024/8 | 6.49 | 0.39 | 50.08 | 45.22 | 51.08 | 18.95 | 0.33 | 本業及子公司營收成長。 | ||
| 2024/7 | 6.46 | 7.62 | 56.89 | 38.73 | 51.25 | 18.67 | 0.33 | 本業及子公司營收成長。 | ||
| 2024/6 | 6.0 | -3.38 | 59.47 | 32.24 | 50.02 | 17.57 | 0.37 | 本業及子公司營收成長。 | ||
| 2024/5 | 6.21 | 16.0 | 77.54 | 26.27 | 48.18 | 17.2 | 0.38 | 本業及子公司營收成長。 | ||
| 2024/4 | 5.35 | -4.86 | 59.32 | 20.05 | 40.96 | 14.27 | 0.46 | 2023年度成立子公司衡星與併購美國SACO公司，納入合併營收 | ||
| 2024/3 | 5.63 | 71.12 | 29.59 | 14.7 | 35.29 | 14.7 | 0.39 | - | ||
| 2024/2 | 3.29 | -43.1 | -4.9 | 9.07 | 39.08 | 13.66 | 0.42 | - | ||
| 2024/1 | 5.78 | 26.03 | 88.77 | 5.78 | 88.77 | 15.7 | 0.37 | 2023年度成立子公司衡星與併購美國SACO公司，納入合併營收 | ||
| 2023/12 | 4.59 | -13.9 | 32.13 | 49.6 | 14.68 | 14.8 | 0.38 | - | ||
| 2023/11 | 5.33 | 8.99 | 26.15 | 45.01 | 13.15 | 15.09 | 0.37 | - | ||
| 2023/10 | 4.89 | 0.31 | 31.76 | 39.69 | 11.61 | 14.08 | 0.4 | - | ||
| 2023/9 | 4.87 | 12.76 | 26.83 | 34.8 | 9.26 | 13.31 | 0.45 | - | ||
| 2023/8 | 4.32 | 4.95 | 6.83 | 29.93 | 6.85 | 12.2 | 0.5 | - | ||
| 2023/7 | 4.12 | 9.39 | 4.99 | 25.61 | 6.86 | 11.38 | 0.53 | - | ||
| 2023/6 | 3.76 | 7.55 | 2.43 | 21.49 | 7.22 | 10.62 | 0.53 | - | ||
| 2023/5 | 3.5 | 4.1 | -7.37 | 17.73 | 8.3 | 11.2 | 0.5 | - | ||
| 2023/4 | 3.36 | -22.62 | 4.19 | 14.23 | 13.0 | 11.16 | 0.5 | - | ||
| 2023/3 | 4.34 | 25.57 | 42.81 | 10.87 | 16.04 | 10.87 | 0.52 | - | ||
| 2023/2 | 3.46 | 12.94 | 27.03 | 6.52 | 3.16 | 9.99 | 0.56 | - | ||
| 2023/1 | 3.06 | -11.77 | -14.9 | 3.06 | -14.9 | 10.76 | 0.52 | - | ||
| 2022/12 | 3.47 | -17.8 | -8.67 | 43.25 | 11.57 | 11.4 | 0.56 | - | ||
| 2022/11 | 4.22 | 13.84 | 9.37 | 39.78 | 13.77 | 11.77 | 0.55 | - | ||
| 2022/10 | 3.71 | -3.43 | 32.27 | 35.56 | 14.32 | 11.6 | 0.55 | - | ||
| 2022/9 | 3.84 | -5.01 | 6.23 | 31.85 | 12.54 | 11.81 | 0.6 | - | ||
| 2022/8 | 4.04 | 3.14 | 16.61 | 28.01 | 13.46 | 11.64 | 0.61 | - | ||
| 2022/7 | 3.92 | 6.72 | 16.94 | 23.96 | 12.95 | 11.37 | 0.63 | - | ||
| 2022/6 | 3.67 | -2.74 | 7.88 | 20.04 | 12.2 | 10.68 | 0.75 | - | ||
| 2022/5 | 3.78 | 17.1 | 34.54 | 16.37 | 13.22 | 10.04 | 0.8 | - | ||
| 2022/4 | 3.23 | 6.05 | -0.96 | 12.59 | 8.08 | 8.99 | 0.9 | - | ||
| 2022/3 | 3.04 | 11.7 | 1.96 | 9.36 | 11.6 | 9.36 | 0.87 | - | ||
| 2022/2 | 2.72 | -24.34 | 20.89 | 6.32 | 16.91 | 10.12 | 0.8 | - | ||
| 2022/1 | 3.6 | -5.31 | 14.08 | 3.6 | 14.08 | 11.26 | 0.72 | - | ||
| 2021/12 | 3.8 | -1.56 | 2.29 | 38.76 | 8.24 | 10.47 | 0.75 | - | ||
| 2021/11 | 3.86 | 37.68 | 2.47 | 34.96 | 8.93 | 10.28 | 0.76 | - | ||
| 2021/10 | 2.8 | -22.44 | -2.58 | 31.1 | 9.79 | 9.89 | 0.79 | - | ||
| 2021/9 | 3.62 | 4.26 | 13.23 | 28.3 | 11.19 | 10.44 | 0.67 | - | ||
| 2021/8 | 3.47 | 3.44 | 8.67 | 24.68 | 10.9 | 10.23 | 0.69 | - | ||
| 2021/7 | 3.35 | -1.53 | 0.38 | 21.21 | 11.27 | 9.57 | 0.74 | - | ||
| 2021/6 | 3.41 | 21.29 | 6.14 | 17.86 | 13.58 | 9.47 | 0.66 | - | ||
| 2021/5 | 2.81 | -13.79 | -2.38 | 14.45 | 15.49 | 9.05 | 0.69 | - | ||
| 2021/4 | 3.26 | 9.19 | 4.13 | 11.65 | 20.82 | 8.49 | 0.73 | - | ||
| 2021/3 | 2.98 | 32.43 | 23.06 | 8.39 | 28.85 | 8.39 | 0.66 | - | ||
| 2021/2 | 2.25 | -28.6 | 48.59 | 5.41 | 32.28 | 9.12 | 0.6 | - | ||
| 2021/1 | 3.15 | -15.1 | 22.66 | 3.15 | 22.66 | 10.64 | 0.52 | - | ||
| 2020/12 | 3.72 | -1.38 | 26.86 | 35.81 | -2.19 | 10.36 | 0.51 | - | ||
| 2020/11 | 3.77 | 30.88 | 3.91 | 32.1 | -4.72 | 9.84 | 0.54 | - | ||
| 2020/10 | 2.88 | -9.85 | -6.95 | 28.33 | -5.76 | 9.26 | 0.57 | - | ||
| 2020/9 | 3.19 | 0.05 | 1.83 | 25.45 | -5.62 | 9.73 | 0.68 | - | ||
| 2020/8 | 3.19 | -4.44 | -11.62 | 22.26 | -6.61 | 9.74 | 0.67 | - | ||
| 2020/7 | 3.34 | 4.1 | -9.7 | 19.06 | -5.71 | 9.42 | 0.7 | - | ||
| 2020/6 | 3.21 | 11.54 | 14.02 | 15.72 | -4.82 | 9.21 | 0.74 | - | ||
| 2020/5 | 2.88 | -8.04 | -7.8 | 12.52 | -8.68 | 8.43 | 0.81 | - | ||
| 2020/4 | 3.13 | 29.05 | 5.18 | 9.64 | -8.95 | 7.07 | 0.96 | - | ||
| 2020/3 | 2.42 | 59.89 | -14.29 | 6.51 | -14.47 | 6.51 | 0.94 | - | ||
| 2020/2 | 1.52 | -41.06 | -12.69 | 4.09 | -14.58 | 7.02 | 0.87 | - | ||
| 2020/1 | 2.57 | -12.19 | -15.65 | 2.57 | -15.65 | 9.13 | 0.67 | - | ||
| 2019/12 | 2.93 | -19.22 | 12.61 | 36.62 | 4.18 | 0.0 | N/A | - | ||
| 2019/11 | 3.63 | 17.19 | 12.41 | 33.69 | 3.5 | 0.0 | N/A | - |
